EFFECTS OF MATERNAL DIABETES MELLITUS ON THE FETAL LUNG

母亲糖尿病对胎儿肺的影响

基本信息

  • 批准号:
    3068562
  • 负责人:
  • 金额:
    $ 7.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1982
  • 资助国家:
    美国
  • 起止时间:
    1982-07-01 至 1987-06-30
  • 项目状态:
    已结题

项目摘要

The incidence of respiratory distress syndrome (RDS) is increased almost sixfold in infants of diabetic mothers (IDM), even when suitable corrections are made for gestational age. IDMs experience hyperinsulinemia both in utero and in the postnatal period as a result of intrauterine hyperglycemia, particularly when maternal glucose homeostasis is poorly controlled. We propose to examine the hypothesis that hyperinsulinemia secondary to hyperglycemia alters fetal lung maturation using both in vivo and in vitro studies. In vivo studies: Exogenous glucose will be infused into chronically catheterised fetal lambs from which tracheal fluid can be continuously collected. Surface activity of the tracheal fluid will be assayed on a surface balance and surfactant concentration and flux in tracheal fluid will be quantified. Lipid analysis of the tracheal fluid will be carried out in order to delineate surfactant composition. Respiratory surface area and the stability index of lungs will be derived from pressure-volume curves of excised lungs. Insulin, cortisol, beta-sympathomimetic, and thyroid hormone receptors will be assayed in nuclear and cytoplasmic fractions of whole lung homogenates. In vitro studies: Alveolar type II cells (greater than 95% purity) and lung fibroblasts (greater than 95% purity) will be separated from organotypic cultures of fetal rabbit lungs (26-31 days gestation) and grown in monolayer culture using Warburton's modification of Douglas' and Sevanian's methods. These preparations will be used to simulate and study the effects of the IDM's fetal environment on interactions between lung cells in three groups of experiments: 1. Effects of fibroblast conditioned media (FCM) prepared with insulin, cortisol, isoxuprine and/or propranolol, and thyroid hormone exposed fibroblasts on growth (3H thymidine DNA incorporation), metabolic rate (14CO2 production) and surfactant synthesis and release (3H choline and 3H myo-inositol incorporation) by alveolar type II cells in comparison with directly treated type II cells. 2. Effects of above FCM on cortisol, insulin, beta-sympathominetic and thyroid hormone receptors in alveolar type II cells. 3. Elaboration of extracellular matrix by lung fibroblasts, its composition and its effects on alveolar type II cell growth, metabolic rate and surfactant production will be studied. In addition, modification of extracellular matrix production by insulin, glucose and cortisol will be studied.
呼吸窘迫综合征(RDS)的发生率几乎呈上升趋势

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of beta-2 agonist on hepatic glycogen metabolism in the fetal lamb.
β2激动剂对胎羔肝糖原代谢的影响。
  • DOI:
    10.1203/00006450-198809000-00011
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Warburton,D;Parton,L;Buckley,S;Cosico,L;Saluna,T
  • 通讯作者:
    Saluna,T
Verapamil: a novel probe of surfactant secretion from rat type II pneumocytes.
维拉帕米:大鼠 II 型肺细胞分泌表面活性剂的新型探针。
Effects of beta-2 agonist on tracheal fluid flow, surfactant and pulmonary mechanics in the fetal lamb.
β2 激动剂对胎羔气管液流、表面活性剂和肺力学的影响。
Effects of beta-2 agonist on metabolic regulation in the fetal lamb lung.
β-2 激动剂对胎羔肺代谢调节的影响。
Beta-receptors and surface active material flux in fetal lamb lung: female advantage.
胎儿羔羊肺中的β受体和表面活性物质通量:雌性优势。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID WARBURTON其他文献

DAVID WARBURTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID WARBURTON', 18)}}的其他基金

Molecular anatomy of human alveolar development
人类肺泡发育的分子解剖学
  • 批准号:
    8870424
  • 财政年份:
    2014
  • 资助金额:
    $ 7.52万
  • 项目类别:
Molecular anatomy of human alveolar development
人类肺泡发育的分子解剖学
  • 批准号:
    9066203
  • 财政年份:
    2014
  • 资助金额:
    $ 7.52万
  • 项目类别:
Environmental and respiratory health across the lifespan in Mongolia
蒙古人一生中的环境和呼吸健康
  • 批准号:
    8337172
  • 财政年份:
    2013
  • 资助金额:
    $ 7.52万
  • 项目类别:
Environmental and respiratory health across the lifespan in Mongolia
蒙古人一生中的环境和呼吸健康
  • 批准号:
    9269894
  • 财政年份:
    2013
  • 资助金额:
    $ 7.52万
  • 项目类别:
Environmental and respiratory health across the lifespan in Mongolia
蒙古人一生中的环境和呼吸健康
  • 批准号:
    8847960
  • 财政年份:
    2013
  • 资助金额:
    $ 7.52万
  • 项目类别:
Excess TGFBeta in Neonatal Lung Injury and Repair
新生儿肺损伤和修复中过量的 TGFβ
  • 批准号:
    7827979
  • 财政年份:
    2009
  • 资助金额:
    $ 7.52万
  • 项目类别:
Excess TGFBeta in Neonatal Lung Injury and Repair
新生儿肺损伤和修复中过量的 TGFβ
  • 批准号:
    7442202
  • 财政年份:
    2007
  • 资助金额:
    $ 7.52万
  • 项目类别:
Excess TGFBeta in Neonatal Lung Injury and Repair
新生儿肺损伤和修复中过量的 TGFβ
  • 批准号:
    7440989
  • 财政年份:
    2006
  • 资助金额:
    $ 7.52万
  • 项目类别:
Excess TGFBeta in Neonatal Lung Injury and Repair
新生儿肺损伤和修复中过量的 TGFβ
  • 批准号:
    6967928
  • 财政年份:
    2004
  • 资助金额:
    $ 7.52万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    6967962
  • 财政年份:
    2004
  • 资助金额:
    $ 7.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了